Società DA32 Life Science Tech Acquisition Corp.
Azioni
DALS
US23312M1062
Società Holding
Attività
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Steven Kafka
CEO | Chief Executive Officer | 54 | 01/04/21 |
Chris Wolfe
DFI | Director of Finance/CFO | 44 | 01/04/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
E. Hrusovsky
BRD | Director/Board Member | 63 | 27/07/21 |
Keith Crandell
BRD | Director/Board Member | 63 | 27/07/21 |
Nicolas Roelofs
BRD | Director/Board Member | 66 | 27/07/21 |
Steven Kafka
CEO | Chief Executive Officer | 54 | 01/04/21 |
Angela Lai
BRD | Director/Board Member | - | 27/07/21 |
Director/Board Member | 42 | 27/07/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 5 000 000 | 0 | 0 | 77,01 % |
Azione B | 1 | 20 650 000 | 19 752 807 ( 95,66 %) | 0 |
Coordinate società
DA32 Life Science Tech Acquisition Corp.
345 Park Avenue South 12th floor
10010, New York
+
![Indirizzo DA32 Life Science Tech Acquisition Corp.(DALS)](https://cdn.zonebourse.com/static/address/125228566.png)
Variaz. 1 gen. | Capi. | |
---|---|---|
+108,23% | 7,01 Mrd | |
+2,71% | 987 Mln | |
+51,02% | 976 Mln | |
+2,39% | 669 Mln | |
-.--% | 600 Mln | |
-2,15% | 593 Mln | |
+10,28% | 536 Mln | |
-.--% | 500 Mln | |
+4,83% | 470 Mln |